- October 24, 2025 - Rose Pharma Inc., a clinical-stage biopharmaceutical company developing ROSE-010, a rapid-onset, short-duration GLP-1 therapy targeting both weight management and acute IBS pain, today announced that Chief Executive Officer Enda Kenny, PhD will present data from its recent clinical trial in weight management at #ObesityWeek2025 (sponsored by The Obesity Society) on Tuesday, November 4, 2025 at 7:30 p.m
Happy to recommend Willow to my friends. Amy Communication has been great
Adding ginger can help soothe nausea and improve digestion
Explore Tonums research on evidence-based, oral metabolic solutions If you're exploring evidence-based options for metabolic health and want to review the science behind oral supplements and clinical trials, visit Tonums research hub to learn about ongoing human studies and data-driven approaches: Explore Tonum Research
Its bacteriostatic properties make it particularly advantageous for long-term storage and repeated use, minimizing the risk of contamination